14 February 2024

Ellogon.ai wins preliminary National Zorginnovatieprijs 2024

We are delighted to announce that Ellogon.ai has emerged victorious as the North Holland preliminary round winner for the esteemed Zorginnovatieprijs. As the chosen scaleup from Amsterdam, Ellogon.ai will proudly present its innovative EIDOS technology at the upcoming national finals on March 21st!

EIDOS, an innovative AI tool developed by Ellogon.ai, is revolutionizing the way cancer patients are selected for immunotherapy. In a field where about 50% of patients do not benefit from traditional immunotherapy treatments, EIDOS offers a promising solution to improve patient outcomes.

During his presentation, Robert Kuipers from Ellogon.ai underscored the significance of precise patient selection, noting that while immunotherapy can greatly enhance patients' quality of life, it comes with a hefty price tag of €150,000 per treatment. He emphasized the urgency of ensuring that the right patients receive this potentially life-saving therapy, especially considering the alarming statistics: every five minutes, 40 individuals in the EU receive a cancer diagnosis, with 14 losing their lives to the disease. Immunotherapy presents a ray of hope, boasting a threefold increase in survival rates.

Developed in collaboration with esteemed institutions like the Netherlands Cancer Institute, EIDOS has received CE certification and is currently in use in four Dutch academic hospitals and one Greek hospital. Its implementation represents a significant advancement in personalized medicine, offering a more targeted approach to cancer treatment.

The regional preliminary of the Zorginnovatieprijs is organised by Amsterdam Economic Board with the Zorg2025 consortium: ROM InWest, Rabobank, Amsterdam AI and Sigra. Together we also organise other Zorg2025 meetings. These are aimed at bringing together healthcare and welfare professionals, industry, researchers and knowledge institutions in the field of health and prevention. The starting point is the sharing of knowledge, new research and innovations.

Vergelijkbaar >

Similar news items

>View all news items >

February 3

DeepSeek Gives European AI Firms a Chance to Compete in the Global AI Race >

According to Reuters , the rise of Chinese AI model DeepSeek presents European startups with an opportunity to catch up with US firms. With significantly lower costs, more companies are switching from OpenAI’s ChatGPT. However, experts warn about regulatory and security concerns.

Privacy concerns over Chinese AI App DeepSeek: European regulators take action >

The Chinese AI app DeepSeek collects extensive user data, including keystroke information, raising major privacy concerns. According to de Volkskrant , European regulators have launched investigations, with Italy already blocking the app.

Can China’s DeepSeek AI Compete with US Tech Giants? >

A recent RTL Z broadcast highlights how DeepSeek , a new Chinese AI model, is shaking up the tech world. Pascal Wiggers, Lecturer in Responsible AI at the Amsterdam University of Applied Sciences, discussed how the model performs similarly to U.S. AI models like ChatGPT but at a fraction of the cost. This raises questions about its impact on the AI market and Europe’s position in the global technology race.